Product NDC: | 16252-536 |
Proprietary Name: | Cabergoline |
Non Proprietary Name: | Cabergoline |
Active Ingredient(s): | .5 mg/1 & nbsp; Cabergoline |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16252-536 |
Labeler Name: | Cobalt Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078035 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080421 |
Package NDC: | 16252-536-08 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (16252-536-08) > 8 TABLET in 1 BOTTLE, PLASTIC |
NDC Code | 16252-536-08 |
Proprietary Name | Cabergoline |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (16252-536-08) > 8 TABLET in 1 BOTTLE, PLASTIC |
Product NDC | 16252-536 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cabergoline |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080421 |
Marketing Category Name | ANDA |
Labeler Name | Cobalt Laboratories |
Substance Name | CABERGOLINE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |